Healthstream (HSTM) Cost of Revenue (2010 - 2026)

Healthstream (HSTM) has 17 years of Cost of Revenue data on file, last reported at $13.0 million in Q1 2026.

• Quarterly Cost of Revenue rose 6.68% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $80.1 million (up 742.2% YoY) and the FY2025 annual result came in at $107.2 million, up 127.34% from the prior year.
• Cost of Revenue eased to $13.0 million in Q1 2026 per HSTM's latest filing, from $28.9 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $28.9 million in Q4 2025 and bottomed at -$25.7 million in Q4 2024.
• The 5-year median for Cost of Revenue is $11.7 million (2023), against an average of $10.6 million.
• The widest annual swing landed in 2023, when Cost of Revenue plunged 319.83%; it then jumped 921.14% in 2025.
• Tracing HSTM's Cost of Revenue over 5 years: stood at $11.5 million in 2022, then sank by 319.83% to -$25.3 million in 2023, then fell by 1.58% to -$25.7 million in 2024, then soared by 212.41% to $28.9 million in 2025, then tumbled by 55.08% to $13.0 million in 2026.
• Per Business Quant, the three latest HSTM Cost of Revenue figures stand at $13.0 million (Q1 2026), $28.9 million (Q4 2025), and $26.5 million (Q3 2025).

Peer Comparison